Calcitriol derivatives with two different side chains at C-20: 24-Hydroxy derivatives as metabolic products and molecular probes for VDR exploration

Journal of Steroid Biochemistry and Molecular Biology

Volumn 89-90, Issue , 2004, Pages 35-38

  Maehr, Hubert ^a   Uskokovic, Milan R ^a   Reddy, G Satyanarayana ^a   Adorini, Luciano ^a  

^a Bioxell Inc   (United States)

Author keywords

24(R) hydroxy gemini; 24(R) hydroxylase; Gemini; Metabolism; Side chain de symmetrization; VDR

Indexed keywords

CALCITRIOL DERIVATIVE; CALCIUM; CELL NUCLEUS RECEPTOR; GAMMA INTERFERON; VITAMIN D RECEPTOR;

ANIMAL EXPERIMENT; CALCIUM BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG MEGADOSE; DRUG STRUCTURE; DRUG SYNTHESIS; HYDROXYLATION; METABOLISM; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; STEREOCHEMISTRY;

ANIMALS; CALCITRIOL; MICE; MOLECULAR PROBES; RECEPTORS, CALCITRIOL;

EID: 3042640663     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2004.03.047     Document Type: Conference Paper

References (16)

1. 3 analog with two side chains. In: A.W. Norman, R. Bouillon, M. Thomasset (Eds.), Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone, University of California, Riverside, 1997, pp 19-21.
2. 3 analogs with bis C-20 side chains for treating or preventing neoplastic diseases, US 6008209 (1999) 13 p.
3. 3 analogs with bis C-20 side chains as therapeutic agents, WO 9849138 (1998) 35 p.
4. 3 with two side chains: interaction with its nuclear receptor and cellular actions. J. Med. Chem. 43:2000;2719-2730
5. 3 is reduced during its metabolism: studies in chronic myeloid leukemia (RWLeu-4) cells and rat kidney. J. Steroid Biochem. Mol. Biol. 78:2001;167-176
6. 3, is in part due to its metabolism into stable intermediary metabolites with significant biological activity. J. Steroid Biochem. Mol. Biol. 71:1999;111-121
7. 3 that resist metabolism through C-24 oxidation and C-3 epimerization pathways. Steroids. 66:2001;463-471
8. 3 produced in rat kidney. Biochem. Pharmacol. 58:1999;1965-1973
9. H. Maehr, Chemical structures are drawn according to a proposed convention, Graphic representation of configuration in two-dimensional space. Current conventions, clarifications, and proposed extensions, J. Chem. Inf. Comput. Sci. 42 (2002) 894-902.
10. H. Maehr, M.R. Uskokovic, A. Norman, J. Bishop, S. Reddy, P. Koeffler, G. Studzinski, DeLuca Symposium on Vitamin D, Taos, New Mexico, 15-19 June 2002, Abstract, p. 42.
11. H. Maehr, M.R. Uskokovic, Formal desymmetrization of the diastereotopic chains in gemini calcitriol derivatives with two different side chains at C-20, Eur. J. Org. Chem. (2004) 1703-1713.
12. Lythgoe B. Synthetic approaches to vitamin D and its relatives. Chem. Soc. Rev. 10:1981;449-475
13. Zhu G.-D., Okamura W.H. Synthesis of vitamin D (calciferol). Chem. Rev. 95:1995;1877-1952
14. Dai H., Posner G.H. Synthetic approaches to vitamin D. Synthesis. 12:1994;1383-1398
15. Baggiolini E.G., Iacobelli J.A., Hennessy B.M., Batcho A.D., Sereno J.F., Uskokovic M.R. Stereocontrolled total synthesis of 1α, 25-dihydroxycholecalciferol and 1α, 25-dihydroxyergocalciferol. J. Org. Chem. 51:1986;3098-3108
16. 3 (24-hydroxylated ED-71). Steroids. 66:2000;267-276